XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | 11. EARNINGS PER SHARE The following table sets forth the components of the denominator for the computation of basic and diluted earnings per share for net loss attributable to Community Health Systems, Inc. stockholders:
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Weighted-average number of shares outstanding — basic |  |  | 130,659,672 |  |  |  | 129,095,571 |  |  |  | 130,176,976 |  |  |  | 128,460,419 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Employee stock options |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Other equity-based awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Weighted-average number of shares outstanding — diluted |  |  | 130,659,672 |  |  |  | 129,095,571 |  |  |  | 130,176,976 |  |  |  | 128,460,419 |
The Company generated a loss attributable to Community Health Systems, Inc. stockholders for each of the three-month and six-month periods ended June 30, 2023 and 2022, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated income during the three months ended June 30, 2023 and 2022, the effect of restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 202,182 shares and 1,152,737 shares, respectively. If the Company had generated income during the six months ended June 30, 2023 and 2022, the effect of the restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 335,188 shares and 1,675,586 shares, respectively.
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive: |  |  |  |  |  |  |  |  |  |  |  |
Employee stock options and restricted stock awards |  |  | 7,191,908 |  |  |  | 4,439,146 |  |  |  | 6,540,493 |  |  |  | 2,858,073 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration